KRAS and colorectal carcinoma: Overall, the advancements in KRAS-targeted therapies outlined in this review underscore the growing momentum in the field and the potential to revolutionize the treatment landscape for KRAS-driven CRC, ultimately improving patient outcomes and quality of life by possibly avoiding toxic chemotherapeutics treatments.